Okyo PharmaOKYO
13F holders, Q4 2025 (December 31)10holders +2
3new positions
2sold out
1famous investor
$1.72avg. 13F price*
At the end of Q4 2025, 10 institutions reported holding Okyo Pharma Ltd. (OKYO) in their 13F filings, up 2 from Q3 2025. 3 opened new positions and 2 sold out. The largest holders were Dauntless Investment Group, LLC ($746K), Renaissance Technologies ($286K) and XTX Topco Ltd ($36K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Okyo Pharma Ltd.
- CUSIP
- G6724L116
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $41K |
| Exits | 2 | $145K |
All 13F filers, Q3 2025 → Q4 2025: 116,594 shares bought and 2,023,038 shares sold, net −1,906,444 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| Dauntless Investment Group, LLC | 2.74% | Reduce -80.5% | 471,523 | $746K |
| Renaissance Technologies | 0.00% | Add +234.9% | 138,000 | $286K |
| XTX Topco Ltd | 0.00% | New | 17,612 | $36K |
| Cerity Partners LLC | 0.00% | No change | 12,812 | $27K |
| Geode Capital Management, LLC | 0.00% | No change | 12,090 | $25K |
| Wealth Enhancement Advisory Services, LLC | 0.00% | No change | 10,000 | $21K |
| UBS Group AG | 0.00% | New | 2,172 | $4K |
| EFG International AG | 0.00% | — | 923 | $2K |
| Osaic Holdings, Inc. | 0.00% | No change | 152 | $314 |
| Morgan Stanley | 0.00% | New | 10 | $21 |
"% of holder's portfolio" is OKYO's weight in each manager's 13F, not the share of Okyo Pharma Ltd. the manager owns.